Future Market Insights (FMI) has released new data forecasting significant growth for the global pharmaceutical cold chain packaging market, projecting a robust compound annual growth rate (CAGR) of 14.8%. The market is anticipated to achieve a valuation of USD 60,100.9 million by 2033.
The latest report highlights polymers as the preferred choice for pharmaceutical cold chain packaging materials, expected to dominate with over 62.1% of the global market share in 2023. Polymer packaging solutions are forecasted to generate an incremental opportunity of USD 37.3 billion through the forecast period ending in 2033.
Request for a Sample of this Research Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13956
Advanced cold chain packaging insulation solutions like VIP (Vacuum Insulated Panels) are being proposed for better handling temperature-sensitive pharmaceutical products. Sofrigam states that vacuum insulated panels are capable of providing packaging support of 7-10 days, or even twice or thrice the insulation materials.
Key Takeaways from Pharmaceutical Cold Chain Packaging Market
- North America holds the largest market share with the US being subject to technological advancements. The US International Trade Administration has stated that pharmaceutical cold chain packaging market has undergone drastic changes in the last few years, especially when mode of shipment changed to sea modes from air transportation. This transition could be attributed to the fact that difference in temperature results in pharmaceutical products getting deteriorated.
- Coming to Europe, Germany leads the market. As per Germany Trade and Invest (GTAI), extensive investment in research has put Germany on the top pedestal with respect to pharmaceutical cold chain packaging market. The scenario is expected to persist even in the forecast period.
- The Asia-Pacific is expected to grow at the fastest rate in the pharmaceutical cold chain packaging market in the forecast period. This could be reasoned with countries like India broadly promoting cold chain packaging in the pharmaceuticals vertical and China being one of the hubs of pharmaceuticals.
Competitive Arena:
- Sonoco Thermosafe, in August 2021, announced that it had partnered with Korean Air for leasing the latest shipping container temperature controlled ‘Pegasus ULD’.
- Pelican Products, in February 2021, began distribution of temperature-controlled cases for transportation of Covid-19.
- CSafe Global, in December 2021, completed acquisition of Softbox Systems to make provisions for a one-stop solution for various temperature-sensitive products in the biologics, gene & cell therapy, and upcoming mRNA therapies during the Covid as well as post-Covid era.
- Cold Chain Technologies, in March 2021, entered into partnership with B Medical Systems for offering end-to-end storage and shipping solutions to the life science vertical.
- Softbox Systems Ltd., in January 2018, did acquire TP3 Global to expand its presence across the globe.
Business Growth Drivers:
- Increasing Demand for Biopharmaceuticals: The growing demand for biopharmaceuticals, which often require strict temperature control to maintain their efficacy, has been a significant driver of the cold chain packaging market. Biologics and vaccines, in particular, need to be stored and transported within specific temperature ranges, driving the need for advanced cold chain packaging solutions.
- Rising Healthcare Expenditure: Globally, healthcare expenditure has been increasing, particularly in emerging markets. This increase in spending on healthcare infrastructure and services has led to a higher demand for pharmaceutical products, including those that require cold chain logistics, thereby boosting the cold chain packaging market.
- Stringent Regulations: Regulatory bodies, such as the FDA and EMA, have imposed strict guidelines regarding the transportation and storage of pharmaceutical products. Compliance with these regulations necessitates the use of reliable cold chain packaging solutions, driving market growth.
- Technological Advancements: Continuous advancements in cold chain packaging technologies have enhanced the efficiency, reliability, and safety of pharmaceutical transportation and storage. Innovations such as temperature-monitoring sensors, insulated packaging materials, and active cooling systems have contributed to market expansion.
- Expansion of Biotechnology and Specialty Pharmaceutical Industries: The biotechnology and specialty pharmaceutical sectors have been growing rapidly, driven by advancements in biologics, personalized medicine, and rare disease treatments. These specialized pharmaceutical products often require precise temperature control throughout the supply chain, fueling demand for cold chain packaging solutions.
Industry Restraints:
- High Costs: Implementing and maintaining cold chain logistics can be expensive due to the need for specialized packaging materials, temperature monitoring devices, and transportation infrastructure. The high costs associated with cold chain packaging solutions can act as a barrier to market entry for some pharmaceutical companies.
- Infrastructure Challenges: In certain regions, especially in developing countries and remote areas, inadequate infrastructure such as reliable refrigerated storage facilities and transportation networks poses challenges to maintaining the integrity of the cold chain. This infrastructure gap can hinder market growth by limiting the reach of pharmaceutical products requiring cold chain logistics.
- Complex Supply Chains: The pharmaceutical supply chain is often complex, involving multiple stakeholders and hand-offs between manufacturers, distributors, wholesalers, and retailers. Ensuring seamless temperature control throughout this intricate supply chain can be challenging and may lead to potential disruptions or temperature excursions, impacting product quality and market growth.
- Environmental Concerns: The use of certain cold chain packaging materials, such as expanded polystyrene (EPS) and gel packs, raises environmental concerns due to their non-biodegradable nature and potential for pollution. Increasing awareness and regulations regarding environmental sustainability may drive the development and adoption of eco-friendly cold chain packaging solutions but can also pose challenges in terms of cost and efficacy.
- Risk of Product Loss or Spoilage: Despite advancements in cold chain technologies, there remains a risk of product loss or spoilage due to temperature excursions, equipment failures, or human error. Any incidents of product damage or loss can have significant financial and reputational consequences for pharmaceutical companies, highlighting the importance of robust cold chain packaging solutions and risk management strategies.
The Top Key Players Are:
- Sonoco ThermoSafe
- Cold Chain Technologies
- Sealed Air Corporation
- Nordic Cold Chain Solutions
- Cryopak
- CSafe Global LLC
- TemperPack Technologies, Inc.
- Insulated Product Corp.
- Global Cooling, Inc.
- Envirotainer AB
- va-Q-tec AG
- EMBALL’ISO
- Softbox Systems
- Sofrigam SAS
- DGP Intelsius LLC
- Tempack Packaging Solutions SL
- others
Seize the Opportunity: Get Report Now for a Thorough Report
https://www.futuremarketinsights.com/checkout/13956
Key Segmentations:
By Packaging Format:
- Passive Packaging
- Single-use or One-way Use Packaging
- Multiple Use or Reusable Packaging
- Active Packaging
- Reefer Trucks and Containers
- Active Pallet Containers
By Product:
- Small Boxes
- Pallets
- Single Pallets
- Double Pallets
- Large Sized Pallet Containers
By Material:
- Polymer
- Polyethylene
- Polypropylene
- PET
- EPS
- Polyurethane
- Others
- Metal
- Paper
By Application:
- Biologics and Biological Samples
- Vaccines and Diagnostics
- Others
By End Use:
- Diagnostic Centers
- Clinical Research Organization
- Blood Banks
- Vaccines Packaging Industry
- Pharmaceuticals
- Other Healthcare Units
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
